What is the Share Price of Samsrita Labs Ltd?
- Answer Field
-
The share price of Samsrita Labs Ltd for NSE is ₹ 0.00 and for BSE is ₹ 21.88.
BAJAJ BROKING
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, SAMSRITA LABS LIMITED share price is currently at ₹ 21.88, which is up by ₹ 1.03 from its previous closing. Today, the stock has fluctuated between ₹ 21.88 and ₹ 21.88. Over the past year, SAMSRITA LABS LIMITED has achieved a return of 24.34 %. In the last month alone, the return has been 48.85 %. Read More...
Particulars | MAR 2025 (Values in Cr) |
---|---|
Revenue | 0.00 |
Operating Expense | 0.09 |
Net Profit | -0.09 |
Net Profit Margin (%) | 0.00 |
Earnings Per Share (EPS) | -0.06 |
EBITDA | -0.09 |
Effective Tax Rate (%) | 0.00 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AEGIS LOGISTICS LIMITED | 790.90 | 48.02 | 6.73 | 27760.59 | 574.70 / 1035.70 |
KOTHARI INDUSTRIAL CORPORATION | 276.45 | 49.63 | 18.29 | 2147.57 | 3.82 / 276.45 |
MYSORE PETRO CHEMICALS LTD. | 122.85 | 6.28 | 0.35 | 80.88 | 117.45 / 261.90 |
OSWAL AGRO MILLS LTD | 84.43 | 22.28 | 1.34 | 1133.30 | 41.50 / 108.00 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AEGIS LOGISTICS LIMITED | 790.90 | 64.67 | 11.07 | 27760.59 | 574.70 / 1035.70 |
UTIQUE ENTERPRISES LIMITED | 4.66 | 18.64 | 0.35 | 25.94 | 3.77 / 10.88 |
COMPUTER POINT LTD. | 5.08 | 0.00 | 0.45 | 15.24 | 4.24 / 11.63 |
KOTHARI INDUSTRIAL CORPORATION | 276.45 | 49.63 | 18.31 | 2147.57 | 3.82 / 276.45 |
Samsrita Labs Limited (Formerly known Dr Habeebullah Life Sciences Limited) was incorporated on January 25, 1996. The Company name was changed from Dr Habeebullah Life Sciences Limited to Samsrita Labs Limited on October 13, 2022. The Company, initially focused on three different verticals called, Stem cell related Hospitals, Molecular Diagnostics and R&D in New Drug Discovery but due to other reasons, aimed to shifting into Bio-pharma activities like Trading, Exports & Imports, manufacturing of Bulk drugs, APIs, Specialty drugs, R&D etc through joint ventures or associations or mergers or by its own. The Company is engaged into the business of research & experimental development on natural sciences and engineering, including bio pharma and hospital services also.
In 2017, the Company changed its Main Objects clauses by venturing into the business of Bio-Pharma and also entered the following areas like New Drug Discovery including New Molecular Entity (NME - Pro Drug); Clinical Research Organization (CRO) related activities; Stem Cell - Lab, Research and Therapy; Research and Development in Bio-technology; Consultancy Division and Pharmacy; Academic Services like Courses / Lectures / Seminars on Biotechnology, Pharma, Stem Cell Research and therapy, Clinical Research and animal studies etc.; Nutraceuticals product development; Trading, exporting and importing of medicinal drugs, chemicals, re-agents etc.
In 2016-17, the Company entered into a Collaborative Agreement with Krisani Bio Sciences Private Limited for further development of NASH (Fatty Liver) Molecule and Wilson Disease Molecule on revenue sharing basis and also entered into a Collaborative Agreement with Centre For liver Research And Diagnostics (CLRD) to use their land , building, equipment and other facilities to run their business of Hospital, Diagnostics, Pharmacy, Stem cell and other bio-technology laboratories on revenue sharing basis.
A diversified healthcare company with innovation is at the forefront of research and development in stem cells & regenerative medicine, new drug discovery, RNAi therapeutics, biomarker discovery. The Company was named after late Dr.CM Habeebullah, whose dedication and passion form the backbone of the Company's core values to provide affordable, world class cutting edge healthcare facilities to all. The Company has been established as an advanced center for research and excellence in areas of Stem Cell R&D and Therapy, New Drug discovery, Molecular Diagnostics, Stem cell based multi Specialty Hospital and CRO.
Krisani Bio Sciences Private Limited ceased to be the subsidiary of the Company with effect from 12.11.2021 and was made an Associate Company because of allotment of 64,00,000 equity shares at Rs. 10/- each by Krisani Bio Sciences Private Limited, erstwhile Subsidiary of the Company on a preferential basis and as a result the shareholding of the Company in Krisani Bio Sciences Private Limited came down from 51.33% to 32.91% in 2022.
The share price of Samsrita Labs Ltd for NSE is ₹ 0.00 and for BSE is ₹ 21.88.
The market cap of Samsrita Labs Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 32.40 Cr. as of now.
The 52 Week High and Low of Samsrita Labs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 32.36 and ₹ 12.19.
You can trade in Samsrita Labs Ltd shares with Bajaj Broking by opening a Demat Account.
The 1 year returns on the stock has been 24.34%.
Samsrita Labs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 21.88 as on Apr 30 2025 02:13 PM.
The market cap of Samsrita Labs Ltd for NSE ₹ 0.0 & for BSE ₹ 32.40 as on Apr 30 2025 02:13 PM.
As on Apr 30 2025 02:13 PM the price-to-earnings (PE) ratio for Samsrita Labs Ltd share is -115.78.
As on Apr 30 2025 02:13 PM, the price-to-book (PB) ratio for Samsrita Labs Ltd share is 8.15.
You can trade in Samsrita Labs Ltd shares with Bajaj Broking by opening a demat account.
To buy Samsrita Labs Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Samsrita Labs Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found